Different endotoxin release and IL-6 plasma levels after antibiotic administration in surgical intensive care patients

Journal of Endotoxin Research

Volumn 3, Issue 3, 1996, Pages 261-267

  Holzheimer, R G ^a   Hirte, J F ^a   Reith, B ^a   Engelhardt, W ^a   Horak, K H ^a   Leppert, R ^a   Aasen, A ^b   Capel, P ^c   Urbaschek, R ^d   Karch, H ^a   Thiede, A ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF OSLO   (Norway)

^c UTRECHT UNIVERSITY   (Netherlands)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN; ENDOTOXIN; IMIPENEM; INTERLEUKIN 6; PENICILLIN BINDING PROTEIN; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; BLOOD PRESSURE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GRAM NEGATIVE INFECTION; HEART RATE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; PROSPECTIVE STUDY; SURGICAL PATIENT; TEMPERATURE;

NEGIBACTERIA;

EID: 9344224015     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/096805199600300312     Document Type: Conference Paper

References (35)

1. Jackson J.J., Kropp H. β-lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. J Infect Dis 1992; 165: 1033-1041.
2. Holzheimer R.G., Groß J., Maseizik T. et al. Ischemia and endotoxin mediated inflammatory response (TNF, IL-6, IL-10, TNF-R I+II) in aortic aneurysm repair. Shock 1995; 3 (Suppl.): 15-16.
3. Dofferhoff A.S.M., Nijland J.H., de Vries-Hospers H.G., Mulder P.O.M., Weits J., Bom V.J.J. Effects of different types and combinations of antimicrobial agents on endotoxin release from Gram-negative bacteria: an in-vitro and in-vivo study. Scand J Infect Dis 1991; 23: 745-754.
4. Prins J.M., van Agtmael M.A., Kuijper E.J., Van Deventer S.J.H., Speelman P. Antibiotic-induced endotoxin release in patients with Gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime. J Infect Dis 1995; 172: 886-891.
5. Holzheimer R.G., Molloy R., Mendez M.V. et al. Multiple system organ failure may be influenced by macrophage hypoactivation as well as hyperactivation - importance of the double challenge. Eur J Surg 1995; 161: 795-803.
6. Urbaschek B., Ditter B., Becker K.P., Urbaschek R. Protective effects and role of endotoxin in experimental septicemia. Circ Shock 1984; 14: 209-222.
7. Somberg J.C., Piepho R., Whelton A., Mayor G., Neu H., Laddu A. Clinical therapeutic conference. J Clin Pharmacol 1992; 32: 1083-1088.
8. Holzheimer R.G., Schein M., Wittmann D.H. Inflammatory response in peritoneal exudate and plasma of patients undergoing planned relaparotomy for severe peritonitis. Arch Surg 1995; 130: 1314-1320.
9. Boujoukos A.J., Martich G.D., Supinski E., Suffredini A.F. Compartmentalization of the acute cytokine response in humans after intravenous endotoxin administration. J Appl Physiol 1993; 74: 3027-3033.
10. Bone R.C. The pathogenesis of sepsis. Ann Int Med 1991; 115: 457-469.
11. Parillo J.E. Pathogenesis of human septic shock. Septic shock in humans: advances of understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Int Med 1990; 113: 227-242.
12. Michie H.R., Wilmore D.W. Sepsis, signals, and surgical sequelae (a hypothesis). Arch Surg 1990; 125: 531-536.
13. Prins J.M., Kuijper E.J., Mevissen M.L.C.M., Speelman P., Van Deventer S.J.H. Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentration and presence of septic serum. Infect Immun 1995; 63: 2236-2242.
14. Crosby H.A., Bion J.F., Penn C.W., Elliott T.S.J. Antibiotic induced release of endotoxin from bacteria in vitro. J Med Microbiol 1994; 40: 23-30.
15. Bingen E., Goury V., Bennani H., Lambert-Zechovsky N., Aujard Y., Darbord J.C. Bactericidal activity of β-lactams and amikacin against Haemophilus influenzae: effect on endotoxin release. J Antimicrob Chemother 1992; 30: 165-172.
16. Foca A., Matera G., Berlinghieri M.C. Inhibition of endotoxin activity by antibiotics. J Antimicrob Chemother 1993; 31: 799.
17. Bergeron M.G., Bergeron Y. Influence of endotoxin on the intrarenal distribution of gentamicin, netilmicin, tobramycin, amikacin, and cephalothin. Antimicrob Agents Chemother 1986; 29: 7-12.
18. Eng R.H.K., Smith S.M., Fan-Havard P., Ogbara T. Effect of antibiotics on endotoxin release from Gram-negative bacteria. Diagn Microbiol Infect Dis 1993; 16: 185-189.
19. Simon D.M., Koenig G., Trenholme G.M. Differences in release of tumor necrosis factor from THP-1 cells stimulated by filtrates of antibiotic-killed Escherichia coli. J Infect Dis 1991; 164: 800-802.
20. Cohen J., McConnel J.S. Release of endotoxin from bacteria exposed to ciprofloxacin and its prevention with polymyxin B. Eur J Clin Microbiol 1986; 5: 13-17.
21. Dofferhoff A.S.M., Esselink M.T., de Vries-Hospers H.G. et al. The release of endotoxin from antibiotic-treated Escherichia coli and the production of tumour necrosis factor by human monocytes. J Antimicrob Chemother 1993; 31: 373-384.
22. Hurley J.C., Louis W.J., Tosolini F.A., Carlin J.B. Antibiotic-induced release of endotoxin in chronically bacteriuric patients. Antimicrob Agents Chemother 1991; 35: 2388-2394.
23. Arditi M., Kabat W., Yogev R. Antibiotic-induced bacterial killing stimulates tumor necrosis factor-α release in whole blood. J Infect Dis 1993; 167: 240-244.
24. Foca A., Matera G., Iannello D., Berlinghieri M.C., Liberto M.C. Aminoglycosides modify the in vitro metachromatic reaction and murine generalized Swartzman phenomenon induced by Salmonella minnesota R595 lipopolysaccharide. Antimicrob Agents Chemother 1991; 35: 2161-2164.
25. Hurley J.C. Concordance of endotoxemia with Gram-negative bacteremia in patients with Gram-negative sepsis: a metaanalysis. J Clin Microbiol 1994; 32: 2120-2127.
26. Urbaschek R., Becker K.P. Endotoxinnachweis im Plasma: Spezifität und Aussagekraft für Entwicklung und Prognose einer Sepsis. Infusionther Transfusionsmed 1993; 20 (Suppl 1): 16-20.
27. Kita E., Sawki M., Mikasa K. et al. Proliferation of erythromycin-stimulated mouse peritoneal macrophages in the absence of exogenous growth factors. Nat Immun 1993; 12: 326-338.
28. Yoshimura T., Kurita C., Yamazaki F. et al. Effects of roxithromycin on proliferation of peripheral blood mononuclear cells and production of lipopolysaccharide-induced cytokines. Biol Pharm Bull 1995; 18: 876-881.
29. Nomura S., Kuroiwa A., Nagayama A. Changes of surface hydrophobicity and charge of Staphylococcus aureus treated with sub-MIC of antibiotics and their effects on the chemiluminescence response of phagocytic cells. Chemotherapy 1995; 41: 77-81.
30. Abdelghaffar H., Mtaraig E.M., Labro M.T. Effects of dirithromycin and erythromyccylamine on human neutrophil degranulation. Antimicrob Agents Chemother 1994; 38: 1548-1554.
31. Callery M.P., Kamei T., Flye M.W. Endotoxin stimulates interleukin-6 production by human Kupffer cells. Circ Shock 1992; 37: 185-188.
32. Seatter S.C., Clair L., Bennett T., Bubrick M., West M.A. Independent signal transduction pathways for IL-1 and TNF in LPS-tolerant macrophages. J Surg Res 1995; 58: 651-658.
33. Denis M. Interleukin-6 in mouse hypersensitivity pneumonitis: changes in lung free cells following depletion of endogenous IL-6 or direct administration of IL-6. J Leukoc Biol 1992; 52: 197-201.
34. Riedy M.C., Stewart C.C. Inhibitory role of interleukin-6 in macrophage proliferation. J Leukoc Biol 1992; 52: 125-127.
35. Hof H., Kretschmar M., Budeanu C.H., Nichterlein T.H. Die immunmodulatorische Wirkung von Antibiotika. In: Hacker J., Heesemann J. (Eds), Modulation der Virulenz von Krankheitserregern. SMV, 1994; 52-67.